• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Pipeline

Pipeline

March 26, 2018
Company Drug/Device Medical Condition Status
Avita Medical RECELL deep partial-thickness (second-degree) burns Phase I trials initiated
Surface Oncology SRF231 advanced solid tumors and hematologic malignancies Phase I trials initiated
Cidara Therapeutics, Inc. rezafungin acetate candidemia and/or invasive candidiasis Phase II trials initiated
Arena Pharmaceuticals, Inc. etrasimod ulcerative colitis Phase II trials initiated
AMO Pharma AMO-02 (tideglusib) neuromuscular diseases Phase II trials initiated
Cavion, Inc. CX-8998 generalized epileptic syndromes Phase IIa trials initiated
Antibe Therapeutics ATB-346 gastric or duodenal ulcers of at least 3 mm diameter with unequivocal depth Phase IIb trials initiated enrolling 244 subjects
Regeneron Pharmaceuticals, Inc. EYLEA (aflibercept) moderately severe to severe non-proliferative diabetic retinopathy Phase III trials initiated
AstraZeneca dapagliflozin type 2 diabetes Phase III trials initiated enrolling 321 subjects
Heron Therapeutics HTX-011 Bunionectomy and hernia repair Phase III trials initiated enrolling 412 subjects

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing